Dna X Inc (SONM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 15,022 | 11,516 | 16,776 | 13,430 | 27,566 |
| Cost of Goods | 10,790 | 8,547 | 13,874 | 8,310 | 21,963 |
| Gross Profit | 4,232 | 2,969 | 2,902 | 5,120 | 5,603 |
| Operating Expenses | 7,398 | 9,986 | 6,465 | 6,685 | 5,878 |
| Operating Income | -2,376 | -6,470 | -2,689 | -1,255 | 688 |
| Interest Expense | 0 | 17 | 0 | 4 | 6 |
| Other Income | -19 | -92 | -92 | -1 | -59 |
| Pre-tax Income | -2,395 | -6,579 | -2,781 | -1,260 | 623 |
| Income Tax | 117 | 37 | 125 | 93 | 96 |
| Net Income Continuous | -2,512 | -6,616 | -2,906 | -1,353 | 527 |
| Net Income | $-2,512 | $-6,616 | $-2,906 | $-1,353 | $527 |
| EPS Basic Total Ops | -9.32 | -25.36 | -11.69 | -6.47 | 2.16 |
| EPS Basic Continuous Ops | -9.32 | -25.40 | -11.78 | -5.75 | 2.20 |
| EPS Diluted Total Ops | -9.32 | -25.36 | -11.69 | -6.30 | 2.16 |
| EPS Diluted Continuous Ops | -9.32 | -25.40 | -11.78 | -5.57 | 2.15 |
| EPS Diluted Before Non-Recurring Items | -9.35 | -25.36 | -12.59 | -5.40 | N/A |
| EBITDA(a) | $-1,458 | $-5,625 | $-1,809 | $-299 | $755 |